United States · FDA National Drug Code directory
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42858-215_fc3523da-50f2-4962-8fdc-eee17997dcd1
- Product NDC
- 42858-215
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE
- Labeler
- Rhodes Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190822
- Source listing expiry
- 20271231
Source-listed ingredients
- DEXTROAMPHETAMINE SACCHARATE — 3.75 mg/1
- AMPHETAMINE ASPARTATE MONOHYDRATE — 3.75 mg/1
- DEXTROAMPHETAMINE SULFATE — 3.75 mg/1
- AMPHETAMINE SULFATE — 3.75 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (42858-215-01) · 42858-215-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →